Skip to main content
Clinical Trials/JPRN-UMIN000031780
JPRN-UMIN000031780
Completed
Phase 3

Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study) - Extensive Peritoneal Lavage for Gastric Cancer (P3)

ational University Hospital, Singapore0 sites800 target enrollmentStarted: March 21, 2018Last updated:
ConditionsGastric cancer

Overview

Phase
Phase 3
Status
Completed
Sponsor
ational University Hospital, Singapore
Enrollment
800

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
21years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients who undergo a palliative gastrectomy. 2\.Patients who undergo a gastrectomy as emergency. 3\.Vulnerable persons under age of 21\. 4\.Patients receiving neoadjuvant therapy. 5\.Patients presented with life\-threatening bleeding from tumour 6\.ASA score of 4 \& 5 7\.Patients with another primary cancer within last 5 years 8\.Patients with gross peritoneal and liver metastasis at surgery.

Investigators

Sponsor
ational University Hospital, Singapore

Similar Trials

Unknown
Not Applicable
Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled TrialGastric Cancer
NCT02140034National University Hospital, Singapore600
Completed
Phase 3
Effect of peritoneal lavage in elective colorectal surgery: a randomised trialcolorectal cancer
JPRN-UMIN000004967Yokohama City University, Gastroenterological surgery400
Active, not recruiting
Phase 1
A study designed to compare the effect of two treatment types in gastric cancer patients with peritoneal metastasis, standard systemic chemotherapy vs surgery combined with hyperthermic chemotherapy in the abdominal cavity.Gastric cancer with peritoneal carcinomatosis or tumour positive cytologyMedDRA version: 20.0Level: HLTClassification code 10017812Term: Gastric neoplasms malignantSystem Organ Class: 100000004856MedDRA version: 21.0Level: PTClassification code 10061269Term: Malignant peritoneal neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10057647Term: Cytoreductive surgerySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10067093Term: Intraperitoneal hyperthermic chemotherapySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10061965Term: GastrectomySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: LLTClassification code 10052171Term: Peritoneal carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2015-005695-15-DKKI-AV10
Recruiting
Phase 3
Treatment of PERitoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: the PERISCOPE II studyAdenocarcinoma of the stomachgastric cancer100179901001799110017998
NL-OMON53132Antoni van Leeuwenhoek Ziekenhuis226
Active, not recruiting
Phase 1
A study designed to compare the effect of two treatment types in gastric cancer patients with peritoneal metastasis, standard systemic chemotherapy vs surgery combined with hyperthermic chemotherapy in the abdominal cavity.Gastric cancer with peritoneal carcinomatosis or tumour positive cytologyMedDRA version: 20.0Level: HLTClassification code 10017812Term: Gastric neoplasms malignantSystem Organ Class: 100000004856MedDRA version: 21.0Level: PTClassification code 10061269Term: Malignant peritoneal neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10057647Term: Cytoreductive surgerySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10067093Term: Intraperitoneal hyperthermic chemotherapySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10061965Term: GastrectomySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: LLTClassification code 10052171Term: Peritoneal carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2015-005695-15-NLKI-AV226